SI-Bone Inc (NASDAQ:SIBN) Chairman Jeffrey W. Dunn sold 40,000 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $19.64, for a total value of $785,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of NASDAQ SIBN opened at $20.03 on Thursday. The stock has a market cap of $480.46 million and a price-to-earnings ratio of -28.21. The business has a 50 day simple moving average of $19.13 and a 200 day simple moving average of $18.14. SI-Bone Inc has a 52 week low of $14.08 and a 52 week high of $23.03. The company has a debt-to-equity ratio of 0.50, a quick ratio of 11.55 and a current ratio of 12.00.
SI-Bone (NASDAQ:SIBN) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.35) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.40) by $0.05. The business had revenue of $16.32 million during the quarter. SI-Bone had a negative return on equity of 84.84% and a negative net margin of 46.59%. On average, analysts predict that SI-Bone Inc will post -1.4 EPS for the current year.
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Northern Trust Corp bought a new stake in SI-Bone during the 4th quarter worth $2,109,000. Geode Capital Management LLC bought a new stake in shares of SI-Bone during the 4th quarter valued at $1,972,000. Bank of America Corp DE bought a new stake in shares of SI-Bone during the 4th quarter valued at $683,000. Legal & General Group Plc bought a new position in SI-Bone in the 4th quarter worth $27,000. Finally, Deutsche Bank AG bought a new position in SI-Bone in the 4th quarter worth $227,000. 42.86% of the stock is owned by institutional investors and hedge funds.
SI-Bone Company Profile
SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Recommended Story: How much money do you need to begin day trading?
Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.